NCT06322277

Use of Low-cost Molecular Diagnostic Techniques as a New Surveillance Model for Diseases Preventable by Vaccinations.

The Regional Pediatric Network and the Use of Low-cost Molecular Diagnostic Techniques Cost as a New Management and Surveillance Model for Diseases Preventable by Vaccinations.
Meyer Children's Hospital IRCCS·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Bacterial Infections
Drug/Device/Intervention
Analysis of biological sample
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Meyer Children's Hospital IRCCS
Location
Arezzo,Florence,Florence,Pisa, Italy
Timeline & enrollment
Phase
N/A
Start date
May 04, 2021
End date
Mar 31, 2025
Enrollment
1 participants
Primary outcome

Incidence rate of major VPDs (vaccine-preventable infectious diseases): pertussis, influenza virus, respiratory syncytial virus, S.pneumoniae, N.meningitidis, H.influenzae.

Summary

Vaccine-preventable disease (VPD) surveillance should be a priority throughout the world. In
 Italy, however, there is limited attention to the epidemiology of VPDs, with the consequence
 that their incidence is largely underestimated. Although notification of vaccine-preventable
 diseases is mandatory, very often the etiologic agents causing VPDs are not identified the
 etiological agents causing the major and most severe infectious diseases in childhood.
 Several reasons underlie the underestimation. For example, not having a good surveillance
 system does not allow us to organize a sustainable prevention project for example based on on
 the introduction of new vaccinations. For example the limited use of low-cost
 high-sensitivity techniques such as real-time PCR, which could, if more widely used, improve
 pathogen identification with 3 times the sensitivity of standard cultural methods. Therefore,
 the idea of this multicenter, biological sample study is to take advantage of the regional
 pediatric network with the goal of improving VPD surveillance and increase awareness of the
 importance of surveillance of preventable diseases with the vaccine within the pediatric
 network.

ICD-10 classifications
Bacterial infection, unspecifiedBacterial, viral and other infectious agentsOther bacterial intestinal infectionsOther bacterial diseasesOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06322277
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06322277 through Pure Global AI's free database. This phase not specified trial is sponsored by Meyer Children's Hospital IRCCS and is currently Recruiting. The study focuses on Bacterial Infections. Target enrollment is 1 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.